Latest News

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

PHILADELPHIA, PA – (BUSINESS WIRE) – May 10, 2022 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been awarded a European Medicines Agency (EMA) grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.

Instem Expands In Silico Toxicology Service To Meet Growing Demand

November 22, 2021 - Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods

Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support

Instem to Release Next Edition of its Leading Computational Toxicology Software Suite

July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance

Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission

View all news



ICAW & EEMGS meeting

May 23 - 26, 2022

Crowne Plaza, Maastricht, The Netherlands

Visit Conference Site

Informa Clinical Data Disclosure Meeting (CDD)

June 13 - 14, 2022

Hybrid Event - Hyatt Regency Coral Gables, Miami

Visit Conference Site

STP 41st Annual Meeting

June 19 - 23, 2022

Austin Marriott Downtown, Austin, Texas, Booth #103

'Communicate the future proposed Microscopic domain additions or changes to the SEND Implementation Guide'
Dan Potenta, SEND Product Specialist

Visit Conference Site


View all events